Thyroid cancer is a common malignant tumor of the head and neck and endocrine system, characterized by high morbidity and low mortality. The main clinical challenge is the treatment of patients with advanced or high-risk thyroid cancer. At present, the study on the molecular pathogenesis of thyroid cancer provide new opportunities for thyroid cancer, including chemotherapy, molecular targeted therapy and immunotherapy.